1. Home
  2. UTMD vs TLSA Comparison

UTMD vs TLSA Comparison

Compare UTMD & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Utah Medical Products Inc.

UTMD

Utah Medical Products Inc.

HOLD

Current Price

$63.27

Market Cap

196.4M

Sector

Health Care

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.43

Market Cap

192.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UTMD
TLSA
Founded
1978
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
196.4M
192.1M
IPO Year
N/A
2000

Fundamental Metrics

Financial Performance
Metric
UTMD
TLSA
Price
$63.27
$1.43
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
13.3K
316.9K
Earning Date
01-29-2026
05-06-2025
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
3.48
N/A
Revenue
$38,520,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$18.30
N/A
Revenue Growth
N/A
N/A
52 Week Low
$51.26
$0.69
52 Week High
$65.00
$2.60

Technical Indicators

Market Signals
Indicator
UTMD
TLSA
Relative Strength Index (RSI) 61.47 42.35
Support Level $60.97 $1.33
Resistance Level $65.00 $1.77
Average True Range (ATR) 1.86 0.11
MACD 0.09 -0.01
Stochastic Oscillator 74.37 20.41

Price Performance

Historical Comparison
UTMD
TLSA

About UTMD Utah Medical Products Inc.

Utah Medical Products Inc is involved in the business of developing, manufacturing, and distributing medical devices that are mainly proprietary, disposable, and for hospital use. The firm produces its products for Blood pressure monitoring, Blood collection, Electrosurgery, Gynecology, Neonatal critical care, perinatology, and Urology. The company's product portfolio includes Electrosurgical pens, Tenacula, Endoscopic bulb irrigators, and Blood bag spikes. Its products are used mainly in critical care areas, labor and delivery departments of hospitals, and outpatient clinics and physicians' offices.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: